Gilbert Lynn Marks - Director at AN2 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
ANTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Gilbert Lynn Marks since 10/9/2024

Holdings reported by Gilbert Lynn Marks for AN2 Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 53.4K $68.9K $1.29 Jul 10, 2025 Direct
Stock Option (Right to Buy) 19.1K May 22, 2025 Direct Common Stock

Transactions reported by Gilbert Lynn Marks for AN2 Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.